Aspirin 300mg dispersible tablets

Land: Storbritannia

Språk: engelsk

Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiv ingrediens:

Aspirin

Tilgjengelig fra:

Aspar Pharmaceuticals Ltd

ATC-kode:

N02BA01

INN (International Name):

Aspirin

Dosering :

300mg

Legemiddelform:

Dispersible tablet

Administreringsrute:

Oral

Klasse:

No Controlled Drug Status

Resept typen:

Valid as a prescribable product

Produkt oppsummering:

BNF: 04070100; GTIN: 5024071230055 5024071230130

Informasjon til brukeren

Aspar Aspirin 300 PIL UTV17 AW(O)pop.pdf 1 17/01/2019 00:26

Preparatomtale

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Dispersible Aspirin Tablets 300mg
Dispersible Aspirin 300mg Tablets
Boots Aspirin 300mg Dispersible Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains active: Aspirin 300mg
Also contains lactose.
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Tablet for Oral Suspension
White flat circular bevel edged tablets embossed with a breakline on
one face and aD
300 on the other.
The tablet can be divided into equal halves.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
_Anti-inflammatory indications: _
Symptomatic relief of sprains, strains, rheumatic pain, sciatica,
lumbago, muscular
aches, fibrositis, joint swelling and stiffness.
_Analgesic and antipyretic indications: _
Mild to moderate pain including headache, migraine, neuralgia,
toothache, sore
throat, period pains, aches and pains, symptomatic relief of influenza
and feverish
colds.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Adults and children over 16 years:_ 1 to 3 tablets every four hours,
or as directed by a
doctor.
Not more than 4 doses in 24 hours.
Do not give to children under 16 years, unless specifically indicated
(e.g. for
Kawasaki’s disease).
_Elderly persons: _Lower dose is recommended.
The tablets are to be taken orally with water.
4.3
CONTRAINDICATIONS
Aspirin is contraindicated in patients with;
•
active peptic ulceration or a history of peptic ulceration.
•
Haemophilia, haemorrhagic disease or a history of bleeding disorders.
•
Gout or a history of gout.
•
Hypersensitivity to aspirin (e.g. asthma, rhinitis, angioedema or
urticaria), other NSAIDs or other tablet excipients
•
During the third trimester of pregnancy
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
There is a possible association between aspirin and Reye’s syndrome
when
given to children. Reye’s syndrome is a very rare disease, which
affects the
brain and liver and can be fatal. For this reason aspirin should not
be given to
children under 16 years unless spe